Study to Identify if Chemist Confessions Retinol Cream Works to Improve the Appearance of Early Signs of Aging.

NCT ID: NCT05039476

Last Updated: 2023-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-01

Study Completion Date

2022-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chemist Confessions has developed a retinol cream with the aim to improve the appearance of early signs of aging, such as fine lines, dark spots, hyperpigmentation, and crow's feet. In this phase, Chemist Confessions plans to collect self-reported outcomes and photographic images to understand the assessment of the efficacy of treatment from the participant's perspective, and if participants see an improvement in their fine lines, wrinkles, dark spots, hyperpigmentation, and crow's feet.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on a review of existing literature and previous studies, retinol has been found to have positive effects, however, due to study limitations, there are also conflicting results. Therefore, in this study, participants will receive Chemist Confessions retinol cream to understand if the Chemist Confessions cream has an impact on the participant's skin, and even potentially reduces fine lines, wrinkles, dark spots, hyperpigmentation, and crow's feet of the skin, and also to understand concepts considered essential by individuals taking retinol products.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wrinkle Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Split face intervention
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Retinol face cream

Retinol face cream on one half of the participant's face

Group Type ACTIVE_COMPARATOR

Retinol face cream

Intervention Type DIETARY_SUPPLEMENT

Retinol face cream

Placebo face cream

Placebo face cream on one half of the participant's face

Group Type PLACEBO_COMPARATOR

Placebo face cream

Intervention Type DIETARY_SUPPLEMENT

Placebo face cream

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Retinol face cream

Retinol face cream

Intervention Type DIETARY_SUPPLEMENT

Placebo face cream

Placebo face cream

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female between 30-50 years old
* Must be in good general health
* Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication
* May experience hyperpigmentation, dark spots and dark circles
* Must maintain the following skincare routine containing: cleansing, allowed moisturizer and study specific sunscreen
* Must use study provided sunscreen daily
* Must discontinue the use of other retinoids 4 weeks before the study start date
* Must have some general knowledge of retinoid use
* Must be willing to comply with the requirements of the protocol
* Must be able to communicate in English
* Must be able to tell left from right
* Must willing to add the retinoid cream to their skincare routine
* Must provide written informed consent form (ICF)
* Is willing and able to share feedback and take skin pictures via the used technology portal
* Must be willing to refrain from using products with chemical exfoliants glycolic acid and lactic acid during the duration of the study

Exclusion Criteria

* Unwilling to provide consent
* Unwilling to add the retinoid cream to their normal skincare routine
* Unwilling to follow the routine of the protocol
* Uses moisturizers that include chemical exfoliating ingredients such as glycolic acid, lactic acid or salicylic acid
* Use of other oral retinoids
* Use of prescription medication relevant to the skin
* Undergoing any cosmetic procedures during the study including Botox, laser or chemical peel treatments
* Deep-set of wrinkles
* Use of prescription drug (topical or oral) that is targeted at any sort of skin condition (for example retinoids)
* Is pregnant or nursing, or attempting a pregnancy
* Used retinoids before with an adverse reaction
* Has a self-identified sensitive skin type
* Has any learning and/or cognitive difficulties that prevent him/her reading and understanding questionnaires and surveys (e.g. dementia)
Minimum Eligible Age

30 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Citruslabs

INDUSTRY

Sponsor Role collaborator

Chemist Confessions, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susanne Mitschke, MSc

Role: PRINCIPAL_INVESTIGATOR

Citruslabs

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Citruslabs

Santa Monica, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20218Chemist

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of PCC1 for Skin Rejuvenation
NCT06641869 COMPLETED NA
Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin
NCT07084116 ENROLLING_BY_INVITATION PHASE2/PHASE3